Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

Table 3 Characteristics of the included studies on CCND1 rs9344 polymorphisms and cancer susceptiblity

First Author	Year	Country	Ethnicity	Cancer type	Source of control	Genotyping method	NOS score	Number of cases	Number of control	Genotype of cases			Genotype of controls			Ref
Cakina S	2013	Turkey	Caucasian	Lung cancer	Unknown	PCR-RFLP	5	75	58	13	37	25	12	31	15	[43]
Catarino R	2013	Portugal	Caucasian	NSCLC	PB	PCR-RFLP	6	342	892	90	175	77	164	512	216	[42]
Gautschi O	2006	Switzerland	Caucasian	NSCLC	PB	PCR-RFLP	6	244	187	66	133	45	55	90	42	[41]
Hsia TC	2011	China	Asian	Lung cancer	HB	PCR-RFLP	7	358	716	46	183	129	119	422	175	[40]
Hung RJ	2006	Europe	Caucasian	Lung cancer	HB	TaqMan	7	2238	2289	609	1081	527	627	1081	500	[39]
Pandey A	2017	India	Caucasian	Lung cancer	HB	PCR-RFLP	5	353	351	62	241	50	84	206	61	[38]
R. Pe´rez-Morales	2013	Mexico	Caucasian	Lung cancer	Unknown	PCR-RFLP	5	190	382	86	84	20	161	156	65	[44]
Qiuling S	2003	China	Asian	Lung cancer	PB	PCR-SSCP	7	182	185	40	85	57	48	98	39	[45]
Sobti RC	2006	India	Caucasian	Lung cancer	HB	PCR-RFLP	4	151	151	29	87	35	39	69	43	[46]
Wang W	2007	American	Caucasian	Lung cancer	HB	TaqMan	7	1290	1241	368	638	284	369	645	227	[47]

Abbreviations HB Hosipital-based, NSCLC Non-small cell lung cancer, PB Population-based, Ref Reference

ISSN: 1471-2466